Multiple sclerosis and hepatitis B vaccination: Could minute contamination of the vaccine by partial hepatitis B virus polymerase play a role through molecular mimicry?

Medical Hypotheses

Volumn 65, Issue 3, 2005, Pages 509-520

  Faure, E ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AUTOANTIGEN; DNA POLYMERASE; HEMOGLOBIN; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PLASMID VECTOR; RECOMBINANT HEPATITIS B VACCINE;

ARTICLE; AUTOIMMUNE DISEASE; CHRONIC HEPATITIS; DISEASE COURSE; DRUG SAFETY; ENZYME INACTIVATION; EXPOSURE; GENETIC LINKAGE; GENETIC TRANSCRIPTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HYPOTHESIS; IMMUNOGENICITY; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MOTIF; PROTEIN SYNTHESIS; RNA TRANSLATION; SEQUENCE HOMOLOGY; VACCINATION; VIRAL CONTAMINATION; VIRUS PARTICLE;

AMINO ACID SEQUENCE; BASE SEQUENCE; GENE PRODUCTS, POL; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS;

HEPATITIS B VIRUS;

EID: 21844442387     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.02.044     Document Type: Article

References (82)

1. C. Seeger, and W.S. Mason Hepatitis B virus biology Microbiol Mol Biol Rev 64 2000 51 68
2. L. Stuyver, S.A. Locarnini, A. Lok, D. Richman, D. Carman, and J.L. Dienstag Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region Hepatology 33 2001 751 757
3. A. Kramvis, M. Kew, and G. François Hepatitis B virus genotypes Vaccine 23 2005 2409 2423
4. FB Hollinger, and TJ Liang DM Knipe PM Howley RM Chanook TP Monath B Roizman SE Straus Fields virology 4th ed. Hepatitis B virus 2001 Lippincott Williams & Wilkins Philadelphia 2971 3036
5. FJ Mahoney, and M. Kane SA Plotkin WA Orenstein Vaccines 3rd ed. Hepatitis B vaccine 1999 WB Saunders Company Philadelphia 158 182
6. B. Waisbren Hepatitis B vaccination and autoimmune problems Wisconsin Med J 95 1996 701 703
7. I. Grotto, Y. Mandel, M. Ephros, I. Ashkenazi, and J. Shemer Major adverse reactions to yeast-derived hepatitis B vaccine - a review Vaccine 16 1998 329 334
8. Y. Shoenfeld, and A. Aron-Maor Vaccination and autoimmunity - 'vaccinosis': A dangerous liaison? J Autoimmun 14 2000 1 10
9. M. Girard Autoimmune hazards of hepatitis B vaccine Autoimmun Rev 4 2005 96 100
10. D.R. Jeffery The use of vaccinations in patients with multiple sclerosis Infect Med 19 2002 73 79
11. F. Trevisani, G.C. Gattinara, and P. Caraceni Transverse myelitis following hepatitis B vaccination J Hepatol 19 1993 317 318
12. G. Kaplanski, F. Retornaz, J.M. Durand, and J. Soubeyrand Central nervous system demyelination after vaccination against hepatitis B and HLA haplotype J Neurol Neurosurg Psychiatry 58 1995 758 759
13. A. Tourbah, O. Gout, and R. Liblau Encephalitis after hepatitis B vaccination: Recurrent disseminated encephalitis or MS? Neurology 53 1999 396 401
14. E. Touze, O. Gout, M.H. Verdier-Taillefer, O. Lyon-Caen, and A. Alperovitch The first episode of central nervous system demyelinization and hepatitis B virus vaccination Rev Neurol 156 2000 242 246
15. M. Hernan, S.S. Jick, M.J. Olek, and H. Jick Recombinant hepatitis B vaccine and the risk of multiple sclerosis. A prospective study Neurology 63 2004 838 842
16. Engerix B (SK & F). In: Krogh CME, editor. CPS Compendium of pharmaceuticals and specialties, 24th ed. Ottawa: Canadian Pharmaceutical Association; 1989. p. 364-5
17. Recombivax HB (MSD). In: Krogh CME, editor. CPS Compendium of pharmaceuticals and specialties, 24th ed. Ottawa: Canadian Pharmaceutical Association; 1989. p. 874-5
18. Vaccin Genhevac B Pasteur. vaccin contre l'hépatite B. Pasteur vaccins juillet 1988. p. 1-54
19. SL Hauser, and DE Goodin DL Kasper E Braunwald A Fauci S Hauser D Longo JR Jameson Harrison's principles of internal medicine 16th ed. Multiple sclerosis and other demyelinating diseases 2005 McGraw-Hill New York 2461 2471
20. M.B. Oldstone Molecular mimicry and immune-mediated diseases FASEB J 12 1998 1255 1265
21. K.W. Wucherpfennig Mechanisms for the induction of autoimmunity by infectious agents J Clin Invest 108 2001 1097 1102
22. J.E. Libbey, and R.S. Fujinami Are virus infections triggers for autoimmune disease? Clin Microbiol Newsl 24 2002 73 76
23. R.S. Fujinami, and M.B.A. Oldstone Amino acid homology between the encephalitogenic site of myelin based protein and virus: Mechanism for autoimmunity Science 230 1985 1043 1045
24. K.W. Wucherpfennig, and J.L. Strominger Molecular mimicry in T-cell mediated autoimmunity: Viral peptides activate human T-cell clones specific for myelin basic protein Cell 80 1995 695 705
25. J.F. Fourneau, J.M. Bach, P.M. van Endert, and J.F. Bach The elusive case for a role of mimicry in autoimmune diseases Mol Immunol 40 2004 1095 1102
26. B. Hemmer, B.T. Fleckenstein, and M. Vergelli Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone J Exp Med 185 1997 1651 1659
27. A.M. Gautam, R.S. Liblau, G. Chelvanayagam, L. Steinman, and T. Boston A viral peptide with limited homology to a self peptide can induce clinical signs of experimental autoimmune encephalomyelitis J Immunol 161 1998 60 64
28. J. Grogan, L. Kramer, A. Nogai, A. Dong, L. Ohde, and M. Schneider-Mergener Cross-reactivity of myelin basic protein-specific T cells with multiple microbial peptides: Experimental autoimmune encephalomyelitis induction in TCR transgenic mice J Immunol 163 1999 3764 3770
29. A.M. Gautam, C.B. Lock, D.E. Smilek, C.I. Pearson, L. Steinman, and H.O. McDevitt Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: Implications in induction of autoimmunity Proc Natl Acad Sci USA 91 1994 767 771
30. W.T. London Hepatitis B virus and antigen antibody complex diseases N Engl J Med 296 1977 1528 1529
31. S. Vento, and A. Eddleston Autoimmunity and liver diseases Prog Liver Dis 9 1990 335 343
32. B.M. McFarlane, C.B. Bridger, and H.M. Smith Autoimmune mechanisms in chronic hepatitis B and delta virus infections Eur J Gastroenterol Hepatol 7 1995 615 621
33. S.H. Han Extrahepatic manifestations of chronic hepatitis B Clin Liver Dis 8 2004 403 418
34. E. Penner, E. Maida, B. Mamoli, and A. Gangl Serum and cerebrospinal fluid immune complexes containing hepatitis B surface antigen in Guillain-Barre syndrome Gastroenterology 82 1982 576 580
35. M. Matsui, R. Kakigi, S. Watanabe, and Y. Kuroda Recurrent demyelinating transverse myelitis in a high titer HBs-antigen carrier J Neurol Sci 139 1996 235 237
36. G. Ray, B. Ghosh, and R. Bhattacharyya Acute hepatitis B presenting as Guillain-Barre syndrome Indian J Gastroenterol 22 2003 228
37. C. Boz, M. Ozmenoglu, G. Aktoz, S. Velioglu, and Z. Alioglu Guillain-Barre syndrome during treatment with interferon alpha for hepatitis B J Clin Neurosci 11 2004 523 525
38. R. Solans, J.A. Bosch, I. Esteban, and M. Vilardell Systemic sclerosis developing in association with the use of interferon alpha therapy for chronic viral hepatitis Clin Exp Rheumatol 22 2004 625 628
39. A.J. Zuckerman Hepatitis vaccine: A note of caution Nature 255 1975 104 105
40. Hilleman MR. Human retroviruses, cancer, and AIDS: Approaches to prevention and therapy, In: Bolognesi D, editor. UCLA Symposia on Molecular and Cellular Biology, New Series, vol. 71. New York: Liss AR Inc.; 1988; Perspectives in the quest for a vaccine against AIDS. p. 291-311
41. + T-cell responses to human myelin protein-derived peptides Proc Natl Acad Sci USA 91 1994 10859 10863
42. + T cells from multiple sclerosis patients J Neuroimmunol 46 1993 33 42
43. B. Gran, B. Bielekova, H.F. McFarland, and R. Martin Development of multiple sclerosis after hepatitis B vaccination Neurology 54 suppl 3 2000 A164
44. M.L. Michel, P. Pontisso, E. Sobczak, Y. Malpiece, R.E. Streeck, and P. Tiollais Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin Proc Natl Acad Sci USA 81 1984 7708 7712
45. M. Kozak Pushing the limits of the scanning mechanism for initiation of translation Gene 299 2002 1 34
46. S. Roychoudhury, and C. Shih Cis rescue of a mutated reverse transcriptase gene of human hepatitis B virus by creation of an internal ATG J Virol 64 1990 1063 1069
47. M.R. Bavand, and O. Laub Two proteins with reverse transcriptase activities associated with hepatitis B virus-like particles J Virol 62 1988 626 628
48. W.L. Hwang, and T.S. Su Translational regulation of hepatitis B virus polymerase gene by termination-reinitiation of an upstream minicistron in a length-dependent manner J Gen Virol 79 1998 2181 2189
49. P. Soussan, F. Garreau, H. Zylderberg, C. Ferray, C. Brechot, and D. Kremsdorf In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA J Clin Invest 105 2000 55 60
50. H.L. Huang, K.S. Jeng, C.P. Hu, C.H. Tsai, S.J. Lo, and C. Chang Identification and characterization of a structural protein of hepatitis B virus: A polymerase and surface fusion protein encoded by a spliced RNA Virology 275 2000 398 410
51. M.A. Feitelson, M.M. Clayton, and L.X. Duan Polymerase-related polypeptides associated with woodchuck hepatitis core antigen (WHcAg) particles Virology 180 1991 430 433
52. T.T. Wu, L.D. Condreay, L. Coates, C. Aldrich, and W.S. Mason Evidence that less-than-full-length pol gene products are functional in hepadnavirus DNA synthesis J Virol 65 1991 2155 2163
53. N. Yuki, N. Hayashi, and A. Kasahara Detection of antibodies against the polymerase gene product in hepatitis B virus infection Hepatology 12 1990 193 198
54. M. Kann, H.G. Kochel, A. Uy, and R. Thomssen Diagnostic significance of antibodies to hepatitis B virus polymerase in acutely and chronically HBV-infected individuals J Med Virol 40 1993 285 290
55. L.X. Rui, Y.M. Park, J.Y. Choi, B.S. Kim, and G. Jung Detection of antibodies against DNA polymerase of hepatitis B virus in HBsAg-positive sera using ELISA Kor J Int Med 13 1998 95 98
56. G.V. Gregorio, H. Jones, and K. Choudhuri Autoantibody prevalence in chronic hepatitis B virus infection: Effect of interferon alfa Hepatology 24 1996 520 523
57. G.V. Gregorio, K. Choudhuri, Y. Ma, A. Vegnente, G. Mieli-Vergani, and D. Vergani Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection J Immunol 162 1999 1802 1810
58. V.K. Singh, H.K. Kalra, K. Yamaki, T. Abe, L.A. Donoso, and T. Shinohara Molecular mimicry between a uveitopathogenic site of S-antigen and viral peptides. Induction of experimental autoimmune uveitis in Lewis rats J Immunol 144 1990 1282 1287
59. J. Kamholz, F. de Ferra, C. Puckett, and R. Lazzarini Identification of three forms of human myelin basic protein by cDNA cloning Proc Natl Acad Sci USA 83 1986 4962 4966
60. H.J. Roth, K.E. Kronquist, N. Kerlero de Rosbo, B.F. Crandall, and A.T. Campagnoni Evidence for the expression of four myelin basic protein variants in the developing human spinal cord through cDNA cloning J Neurosci Res 17 1987 321 328
61. K.W. Wucherpfennig, A. Sette, S. Southwood, C. Oseroff, M. Matsui, and J.L. Strominger Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones J Exp Med 179 1994 279 290
62. M.P. Pender, P.A. Csurhes, R.A. Houghten, P.A. McCombe, and M.F. Good A study of human T-cell lines generated from multiple sclerosis patients and controls by stimulation with peptides of myelin basic protein J Neuroimmunol 70 1996 65 74
63. A.C. Figueiredo, I.R. Cohen, and F. Mor Diversity of the B cell repertoire to myelin basic protein in rat strains susceptible and resistant to EAE J Autoimmun 12 1999 13 25
64. R.R. Voskuhl, D.E. McFarlin, and L.R. Tranquil A novel candidate autoantigen in a multiplex family with multiple sclerosis: Prevalence of T-lymphocytes specific for an MBP epitope unique to myelination J Neuroimmunol 46 1993 137 144
65. F. Galibert, E. Mandart, F. Fitoussi, P. Tiollais, and P. Charnay Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli Nature 281 1979 646 650
66. P Valenzuela, M Quiroga, J Zaldivar, P Gray, and WJ Rutter BN Fields R Jaenisch CF Fox Animal virus genetics The nucleotide sequence of the hepatitis B viral genome and the identification of the major viral genes 1980 Academic Press New York 57 70
67. X. Lin, Z.H. Yuan, L. Wu, J.P. Ding, and Y.M. Wen A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency J Virol 75 2001 11827 11833
68. S.W. Brostoff, and E.H. Eylar The proposed amino acid sequence of the P1 protein of rabbit sciatic nerve myelin Arch Biochem Biophys 153 1972 590 598
69. M.D. Mannie, P.Y. Paterson, D.C. U'Prichard, and F. Flouret Induction of experimental allergic encephalomyelitis in Lewis rats with purified synthetic peptides: Delineation of antigenic determinants for encephalitogenicity, in vitro activation of cellular transfer, and proliferation of lymphocytes Proc Natl Acad Sci USA 82 1985 5515 5519
70. R. Martin, D. Jaraquemada, and M. Flerlage Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple scerosis patients and healthy individuals J Immunol 145 1990 540 548
71. K. Ota, M. Matsui, E.L. Milford, G.A. Mackin, H.L. Weiner, and D.A. Hafler T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis Nature 346 1990 183 187
72. J. Zhang, C.H. Chou, G. Hashim, R. Medaer, and J.C. Raus Preferential peptide specificity and HLA restriction of myelin basic protein-specific T cell clones derived from MS patients Cell Immunol 129 1990 189 198
73. J. Zhang, R. Medaer, G.A. Hashim, Y. Chin, E. van den Berg Loonen, and J.C. Raus Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity, and cytotoxicity Ann Neurol 32 1992 330 338
74. R. Liblau, E. Tournier Lasserve, J. Maciazek, G. Dumas, O. Siffert, and G. Hashim T cell response to myelin basic protein epitopes in multiple sclerosis patients and healthy subjects Eur J Immunol 21 1991 1391 1395
75. E. Ribera, and A. Dukta Polyneuropathy associated with administration of hepatitis B vaccine N Engl J Med 309 1983 614 615
76. J.W. Rose Virus-induced demyelination: From animal models to human disease Mayo Clin Proc 67 1992 903 906
77. D.A. Dyment, G.C. Ebers, and A.D. Sadovnick Genetics of multiple sclerosis Lancet Neurol 3 2004 104 110
78. C.E. Larsen, and C.A. Alper The genetics of HLA-associated disease Curr Opin Immunol 16 2004 660 667
79. K.W. Wucherpfennig Degeneracy of T cell recognition and its relationship to molecular mimicry Mol Immunol 40 2004 1009 1017
80. R.L. Garcea, and L. Gissmann Virus-like particles as vaccines and vessels for the delivery of small molecules Curr Opin Biotech 15 2004 513 517
81. H. Xiao-wen, S.H. Sun, and Z.L. Hu Augmented humoral and cellular immune responses of a hepatitis B DNA vaccine encoding HBsAg by protein boosting Vaccine 23 2005 1649 1656
82. E. Mizukoshi, J. Sidney, and B. Livingston Cellular immune responses to the hepatitis B virus polymerase J Immunol 173 2004 5863 5871